Table 1. Laboratory findings in severe COVID-19 patients and non-infected individuals expressed as mean ± SEM.
| Parameter | Severe COVID-19 patients
mean ± SEM (n = 14) |
Not infected individuals mean ± SEM (n = 20) | p (t-test) |
|---|---|---|---|
| IL-6 (pg/mL) | 250.1 ± 39.07 | 2.135 ± 0.453 | 0.0001 |
| IL-2 (pg/mL) | 4.426 ± 2.177 | 2.005 ± 0.402 | 0.2818 |
| IL-4 (pg/mL) | 1.936 ± 0.268 | 1.956 ± 0.137 | 0.3150 |
| IL-8 (pg/mL) | 108 ± 19.79 | 7.159 ± 1.298 | 0.0001 |
| IL-10 (pg/mL) | 11.14 ± 4.551 | 0.916 ± 0.219 | 0.0001 |
| VEGF (pg/mL) | 530.7 ± 147.1 | 27.04 ± 4.708 | 0.0001 |
| IFN-g (pg/mL) | 1.487 ± 0.745 | 0.389 ± 0.082 | 0.3889 |
| TNF-a (pg/mL) | 5.223 ± 0.751 | 3.646 ± 0.757 | 0.090 |
| IL-1a (pg/mL) | 0.4614 ± 0.263 | 0.2153 ± 0.0422 | 0.7210 |
| MCP-1 (pg/mL) | 891 ± 92.35 | 89.61 ± 12.18 | 0.0001 |
| EGF (pg/mL) | 65.37 ± 17.46 | 24.28 ± 5.367 | 0.0318 |
| d-ROM (U.Carr) | 448.8 ± 30.37 | 271 ± 5.590 | 0.0001 |
| PAT (U.Carr) | 3048 ± 100.1 | 2406 ± 71.55 | 0.0001 |
| OSI | 107.7 ± 14.38 | 21 ± 2.527 | 0.0001 |
| CRP (mg/L) | 144.7 ± 21.38 | 2.1 ± 0.05 | 0.0001 |
| LDH (IU/L) | 823.4 ± 80.02 | 156 ± 20.31 | 0.0001 |
| NLR | 17.08 ± 2.058 | 1.5 ± 0.02 | 0.0001 |
| PLR | 538.2 ± 85.09 | 113 ± 10.35 | 0.0001 |
| D-dimer (ng/mL) | 2688 ± 499.1 | 225 ± 22.75 | 0.0001 |
| WBC (×10 3μL) | 14 ± 2.004 | 6.1 ± 1.365 | 0.0019 |
| ALT (U/L) | 51.93 ± 7.171 | 28.96 ± 2.658 | 0.0018 |
| AST (U/L) | 61.210 ± 7.283 | 30.56 ± 3.487 | 0.0002 |